Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04732728
Status:
COMPLETED
Last Update Posted:
2023-08-14
First Post:
2021-01-27
Brief Title:
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Study Overview
Official Title:
LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LUX-Dx PERFORM
Brief Summary:
The LUX-Dx PERFORM Study will characterize in a general patient population the utilization of the remote programming feature of the Boston Scientific BSC Insertable Cardiac Monitor ICM device The study will also collect data to characterize the performance of arrhythmia detection algorithms Finally data collected will be used to analyze and characterize the ICM system-related safety events
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None